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Whole genome sequencing, 
molecular typing and in vivo 
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Escherichia coli isolates including 
ST131 H30-Rx, H22 and H41 
subclones
María de Toro1, Javier Fernández2,3, Vanesa García2,4, Azucena Mora4, Jorge Blanco  4, 
Fernando de la Cruz5 & M. Rosario Rodicio2
Carbapenem-resistant Enterobacteriaceae, including the increasingly reported OXA-48 Escherichia 
coli producers, are an emerging public health threat worldwide. Due to their alarming detection 
in our healthcare setting and their possible presence in the community, seven OXA-48-producing, 
extraintestinal pathogenic E. coli were analysed by whole genome sequencing as well as conventional 
tools, and tested for in vivo virulence. As a result, five E. coli OXA-48-producing subclones were detected 
(O25:H4-ST131/PST43-fimH30-virotype E; O25:H4-ST131/PST9-fimH22-virotype D5, O16:H5-ST131/
PST506-fimH41; O25:H5-ST83/PST207 and O9:H25-ST58/PST24). Four ST131 and one ST83 isolates 
satisfied the ExPEC status, and all except the O16:H5 ST131 isolate were UPEC. All isolates exhibited 
local inflammatory response with extensive subcutaneous necrosis but low lethality when tested in a 
mouse sepsis model. The blaOXA-48 gene was located in MOBP131/IncL plasmids (four isolates) or within 
the chromosome (three ST131 H30-Rx isolates), carried by Tn1999-like elements. All, except the ST83 
isolate, were multidrug-resistant, with additional plasmids acting as vehicles for the spread of various 
resistance genes. This is the first study to analyse the whole genome sequences of blaOXA-48-positive 
ST131, ST58 and ST83 E. coli isolates in conjunction with experimental data, and to evaluate the in vivo 
virulence of blaOXA-48 isolates, which pose an important challenge to patient management.
Escherichia coli is a common member of the intestine microbiota of warm-blooded vertebrates including humans. 
It can cause a range of conditions, from diarrheagenic diseases to extraintestinal infections1. Extraintestinal path-
ogenic E. coli (ExPEC) lineages are involved in the latter. Within them, the clonal group ST131 and its H30-R and 
H30-Rx subclones (clades C1 and C2), are associated with antimicrobial resistance and have successfully spread, 
creating a global epidemic of multidrug-resistant (MDR) E. coli infections1–3. Treatment of MDR E. coli infections 
has become a serious clinical issue, with carbapenems being one of the last therapeutic options4. Unfortunately, 
carbapenemase production is increasingly been reported in E. coli, as well as in other Enterobacteriaceae4,5. The 
blaOXA-48 gene, which encodes the OXA-48 carbapenem-hydrolysing class D β-lactamase, has been detected in 
several E. coli clonal groups, including ST1316,7. The blaOXA-48 gene is usually located on self-transferable plasmids 
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belonging to the IncL/M incompatibility group (recently re-classified into IncL and IncM8), largely responsible for 
its dissemination between members of the Entebacteriaceae5,8. Occasionally, blaOXA-48 has also been found in the 
E. coli chromosome9,10. In both cases, plasmids and chromosomes, the gene is carried by Tn1999-like composite 
transposons, designated Tn1999.1 to Tn1999.49,11–14.
Due to the alarming emergence of OXA-48-producing E. coli in our healthcare area, this study aimed to (i) 
analyse the genomic diversity of the isolates, using a combination of whole genome sequencing and molecular 
typing; (ii) investigate the role of plasmids in the dissemination of resistance and virulence genes, and (iii) assess 
the lethality of the isolates using a mouse sepsis model. For this purpose, seven OXA-48-producing E. coli recov-
ered between 2012 and 2015 from clinical samples in three different settings within a Spanish city (Oviedo), were 
selected (Table 1).
Results and Discussion
Resistance properties and molecular typing of the isolates. As shown previously for isolates Ec-
HUCA 1 to 315, Ec-HUCA 4 to 7 showed increased MICs to ertapenem. Fortunately, the level of resistance to 
Isolate
Year of 
isolation
Patient 
Sexa/
ageb Originc Sample
Resistance phenotyped/
genese
ERT/IPM/
MER MIC Serotype MLSTf
fimH 
allele Virotypeg Phylogroup
Ec-HUCA 1h 2012 F/46 GSU Surgical wound
AMP, AMC, ETP, IPMI, 
ERYi, NAL, TET/blaTEM-
1b, blaOXA-48, mph(A), 
gyrA-S83L, tet(B)
2/2/0.19 O16:H5 ST131/PST506 H41 nt B2
Ec-HUCA 2h 2012 M/57 ICU Surgical wound
AMP, AMC, CTX, 
ETP, IMPI, [AMKI, 
GEN, TOB], KAN, 
STR, ERYi, SUL, TMP, 
SXT,TET/blaTEM-1b, 
blaOXA-30, blaCTX-M-15, 
blaOXA-48, aph(3′)-Ia, 
aadA1, strB, mph(A), sul1, 
dfrA5, tet(A)
2/2/0.125 O9:H25 ST58/PST24 H27 na B1
Ec-HUCA 3h 2012 M/68 RU Urine
AMP, AMC, ETP, 
IMPI/ampC2, ampH, 
blaOXA-48
2/2/0.38 O25:H5 ST83/PST207 H21 na B2
Ec-HUCA 4 2014 M/45 ICU Surgical wound
AMP, AMC, FOX, 
ETP, IPMI, MER, CHL, 
NAL, SUL, TMP, SXT, 
TET/blaTEM-1c, blaOXA-48, 
cmlA1, gyrA-S83L, sul3, 
tet(A)
4/2/3 O25:H4 ST131/PST9 H22 D5 B2
Ec-HUCA 5 2015 F/79 PCC Urine
AMP, AMC, FOX, 
CTX, ETP, NAL, CIP, 
SXT/blaCTX-M-15, blaOXA-48, 
gyrA-S83L + D87N, parC-
S80I + E84V, folA-W30R
2/0.5/0.38 O25:H4 ST131/PST43 H30 E B2
Ec-HUCA 6 2015 M/80 EU Urine
AMP, AMC, FOX, CTX, 
ETP, CHL, NAL, CIP, 
SXT, TMP/blaCTX-M-15, 
blaOXA-48, gyrA-
S83L + D87N, parC-
S80I + E84V, qnrS1, 
dfrA14
2/0.5/0.38 O25:H4 ST131/PST43 H30 E B2
Ec-HUCA 7 2015 F/86 GU Urine
AMP, AMC, FOX, CTX, 
ETP, CHL, NAL, CIP, 
SXT, TMP/blaCTX-M-15, 
blaOXA-48, gyrA-
S83L + D87N, parC-
S80I + E84V; parE-I529L, 
qnrS1, dfrA14
2/0.5/0.38 O25:H4 ST131/PST43 H30 E B2
Table 1. Origin, resistance properties and molecular typing of OXA-48 β-Lactamase Escherichia coli isolates 
from a Spanish hospital. aF, female; M, male. byears old. cGSU, general surgery unit-HUCA; ICU, intensive 
care unit-HUCA; RU, reanimation unit-HUCA; PCC, primary-care center; EU, emergency unit-HUCA; GU, 
geriatric unit of a long-term care facility; HUCA, Hospital Universitario Central de Asturias. dAMP, ampicillin; 
AMC, amoxicillin-clavulanic acid; FOX, cefoxitin; CTX, cefotaxime; ETP, ertapenem; IMP, imipenem; MER, 
meropenem; CHL, chloramphenicol, AMK, amikacin; GEN, gentamicin; KAN, kanamycin; TOB, tobramycin; 
STR, streptomycin, ERY, erythromycin; NAL, nalidixic acid; CIP, ciprofloxacin; SUL, sulfonamides; TMP, 
trimethoprim; SXT, trimethoprim-sulfamethoxazole; TET, tetracycline; I, intermediate resistance. eAll 
resistance genes were in silico determined; blaCTX-M-15 and blaOXA-48 were also experimentally detected by PCR 
amplification. Plasmid genes are underlined (see Table 2 for details). fST, sequence type according to Achtman; 
PST, sequence type according to the Pasteur Institute. gThe virotype was determined by PCR based on the 
presence or absence of 13 virulence genes33; nt, not typeable; na, not applicable. hIsolates partially characterized 
in a previous study15. iMIC of erythromycin: 256 µg/ml, higher than that obtained for isolates lacking mph(A): 
128 µg/ml (Ec-HUCA 3, Ec-HUCA 5, Ec-HUCA 6, Ec-HUCA 7) or 64 µg/ml (Ec-HUCA 4).
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other carbapenems was low. In fact, all isolates except Ec-HUCA-4 were susceptible to meropenem, so this drug 
could have been included in the therapy regimen for the treatment of the affected patients (Table 1). In addi-
tion, all isolates were positive in the modified Hodge and the Carba NP tests, and contained the blaOXA-48 gene 
(Table 1). In Ec-HUCA 1 to 4 the blaOXA-48 gene was carried by conjugative plasmids of about 60 Kb, experimen-
tally assigned to the IncL group. The blaOXA-48 gene was chromosomally located in Ec-HUCA 5 to 7. All isolates 
except Ec-HUCA 3 were also resistant to other antimicrobial agents, including fluoroquinolones, aminoglyco-
sides, trimethoprim-sulfamethoxazole and broad spectrum cephalosporins (Table 1). The latter resistance was 
detected in four isolates (Ec-HUCA 2, 5, 6 and 7), which tested positive for blaCTX-M-15 by PCR amplification and 
sequencing.
Five out of the seven isolates were identified as ST131 by the Achtman scheme16 and further differentiated 
into PST43 (Ec-HUCA 5 to 7), PST9 (Ec-HUCA 4) and PST506 (Ec-HUCA 1) according to the Pasteur Institute 
scheme17 (Table 1). All ST131 isolates belonged to serotype O25:H4, except Ec-HUCA 1 which was O16:H5. 
The three O25:H4-ST131/PST43 isolates carried fimH30, were resistant to fluoroquinolones and positive for 
blaCTX-M-15, thus belonged to subclone H30-Rx. The remaining two isolates (Ec-HUCA 2 and 3) showed different 
serotypes (O9:H25 and O25:H5), STs (ST58 and ST83), PSTs (PST24 and PST207) and fimH alleles (H27 and 
H21) (Table 1). ST58 has been identified in isolates of different origins (human, animal and environment), and 
was frequently associated with CTX-M production, particularly CTX-M-118,19. However, besides Ec-HUCA-2, 
only one other ST58 OXA-48-producer has been reported20. In contrast to ST131 and ST58, little information 
exists on ST83, which was previously found in uropathogenic E. coli from cats21. In addition, a query of the 
Enterobase database (version 6th May 2017) identified 22 ST83 entries from different sources (human, companion 
animals, wildlife and environment) and geographical regions. The presence of blaOXA-48 in the otherwise suscep-
tible Ec-HUCA 3, demands further surveillance of the ST83 lineage. By PCR, the ST131 and ST83 isolates were 
assigned to phylogroup B2, while the ST58 isolate belonged to phylogroup B1.
The isolates were also analysed by XbaI-PFGE electrophoresis. The dendrogram generated from comparison 
of the macrorestriction profiles was consistent with the genetic diversity of the isolates. Thus, only the three 
ST131/PST43 H30-Rx isolates of virotype E clustered with similarity ≥85%. The remaining two ST131 isolates 
(Ec-HUCA 1 and 4) presented 76.7% and 65% similarity with that cluster (Supplementary Figure S1). Although 
the high diversity of the ST131 clonal group has been widely reported3,22, it was unexpected for this specific group 
of five ST131 OXA-48-producing isolates, since they were obtained in the same health area over a relatively short 
period of time.
Sequencing of OXA-48-producing isolates and plasmid reconstruction. The draft genomes of 
the seven E. coli isolates yielded 22 to 135 contigs larger than 1 Kb, with assembly sizes ranging from 4.9 Mb 
(Ec-HUCA 3) to 5.4 Mb (Ec-HUCA 4); (average of 5.2 ± 0.137 Mb). This is the first time that the genomes of 
OXA-48-producing ST131 E. coli isolates of subclones H30-Rx, H22 and H41, ST58 and ST83 were sequenced. In 
silico determinations of serotypes, STs/PSTs and fimH alleles fully agreed with experimental data.
In order to establish the plasmid content of the seven E. coli genomes, the PLACNET protocol23 was used 
for plasmid reconstruction (Supplementary Figure S2). As shown in Table 2, plasmids were found in all iso-
lates in numbers ranging from one (Ec-HUCA 5) to seven (Ec-HUCA 4). In the genomes of Ec-HUCA 2 and 
4, PLACNET identified two plasmids that could not be separated and accounted for a total of 348 Kb [IncF 
(F2/51/40:A-:B1)] and 253 Kb [IncF (F2:A-:B1) plus IncI1 (ST48)], respectively. Plasmid extraction followed by 
visualization on agarose gels resolved two plasmids of ca. 140 and 110 Kb in Ec-HUCA 4, a single plasmid band 
of 150 Kb in Ec-HUCA 2 (maybe two plasmids of similar sizes), and fully confirmed the existence of all other 
plasmids reconstructed by PLACNET (Supplementary Figure S3).
Overall, the seven E. coli genomes included 23 plasmids, which were classified as MOBP51/ColE1-like, 
MOBP131/IncL, MOBF12/IncF, MOBF11/IncN, MOBP3/IncX and MOBP12/IncI (Table 2). For one MOBQ12 plasmid 
the incompatibility group was not determined and two other plasmids could not be affiliated with any of the 
MOB categories. Finally, a MOBH2 relaxase was identified in the chromosome of Ec-HUCA 1, consistent with the 
presence of an integrative and conjugative element.
In four out of the seven E. coli isolates (Ec-HUCA 1 to 4; Table 2), the MOBP131/IncL plasmids were experi-
mentally and in silico linked with the blaOXA-48 gene. Their genetic relationship was assessed by building a phyloge-
netic tree, which also included other IncL and IncM plasmids present in the GenBank-NCBI database (Fig. 1). 
Assignment to one or the other Inc group was corroborated in silico, or newly determined using the primers 
reported by Carattoli et al.8. The tree separated IncL and IncM plasmids in two clusters, the latter with two sub-
clusters, IncM1 and IncM2, as previously observed8. Interestingly, blaOXA-48 was not only carried by IncL plasmids 
but also by IncM1 plasmids, formerly classified as IncL/M24,25. Besides, it was found also on IncA/C plasmids26. 
The backbones of the IncL plasmids from the HUCA isolates were identical to each other and to nine other 
IncL plasmids, originating in Klebsiella pneumoniae, Citrobacter freundi, Raoultella planticola and E. coli. These 
results underline the prevalence of an IncL plasmid lineage which plays a major role in the horizontal spread of 
blaOXA-48 between members of the Enterobacteriaceae5. BRIG comparison of the IncL plasmids is shown in Fig. 2. 
The pEc-HUCA and pE71T27 plasmids are highly similar to pOXA-4811. pCF29 (Accession Number LN864820) 
showed a large gap at the mobilization-transfer region (24–39 Kb); whereas pCTX-M328 and pNDM-HK29 lack 
the blaOXA-48 region (2.5–8 Kb), as expected.
Genetic environment of the blaOXA-48 gene. As already indicated, blaOXA-48 was carried by MOBP131/
IncL plasmids in four E. coli isolates, but chromosomally located in another three (Table 2). Although the DNA 
surrounding blaOXA-48 could not be assembled from the short Illumina reads, the location of the gene within 
Tn1999-like transposons and the genetic environment of the transposons was established by PCR mapping. 
Specifically, blaOXA-48 was carried by Tn1999.2 in Ec-HUCA 4; an inverted Tn1999.2 in Ec-HUCA 1 to 3; and an 
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Isolate
Plasmids 
Chromosome Size (bp) Contigs
Relaxase 
proteina,e Replication roteina,e
Inc group 
(pMLST)b,e
Resistance 
genesc,e Virulence genesd,e
Ec-HUCA 1
pEc-HUCA 1_1 131330 26 MOBF12 RepFII, RepFIB IncF (F29:A-:B10)
blaTEM-1b, mph(A), 
tet(B) senB, finO, traT
pEc-HUCA 1_2 61395 6 MOBP131
IncFII_RepA_superfamily 
(pfam02387) IncL/M blaOXA-48 nd
pEc-HUCA 1_3 40230 6 MOBF11
Rep3_superfamily 
(pfam01051) IncN (ST9) nd nd
pEc-HUCA 1_4 34530 4 MOBP3
Rep3_superfamily 
(pfam01051) IncX1 nd nd
ICE_Ec-HUCA 1 201132 f 1 MOBH2 nd nd nd nd
Chr_Ec-HUCA 1 4903773 62 na na na gyrA-S83L
gad, fimABCDEFGHI, ibeBC, 
iha, pic, sfaX, usp, matB, betA, 
irp2, sitC, fyuA/psn
Ec-HUCA 2
pEc-HUCA 
2_1 + 2 347908 346 MOBF12 RepFII (x3), RepFIB
IncF 
(F2/51/40:A:B1)
blaTEM-1b, 
blaOXA-30, 
blaCTX-M-15, 
aadA1, strB, 
aph(3’)-Ia, 
mph(A), sul1, 
dfrA5, tet(A)
iroN, mchF, ompT, sitC, cba, 
hlyF, iroBCDE, iss, iucABCD, 
iutA, etsABC, finO, traT, cvaC
pEc-HUCA 2_3 61304 6 MOBP131
IncFII_RepA_superfamily 
(pfam02387) IncL/M blaOXA-48 nd
pEc-HUCA 2_4 6187 1* MOBQ12
Replicase 
(pfam03090) + priCT1 (pfam 
08708)
nd nd celB
pEc-HUCA 2_5 3003 1* MOBP51 RNAI-II replication system ColE-like nd nd
Chr_Ec-HUCA 2 4741812 134 na na na nd
gad, lpfA, fimABCDEFGHI, 
ibeBC, matB, betA, irp2, fyuA/
psn, iss
Ec-HUCA 3
pEc-HUCA 3_1 111201 1* no-MOB nd nd nd nd
pEc-HUCA 3_2 61879 6 MOBP131
IncFII_RepA_superfamily 
(pfam02387) IncL/M blaOXA-48 nd
Chr_Ec-HUCA 3 4747878 64 na na na ampC2, ampH
gad, pic, fimABCDEFGHI, 
ibeABC, sfaX, usp, matB, 
betA, irp2, sitC, fyuA/psn, vat, 
papBCDFHJK
Ec-HUCA 4
pEc-HUCA 
4_1 + 2 253046 24 MOBF12 + MOBP12
RepFII, RepFIB, 
IncFII_RepA_superfamily 
(pfam02387)
IncF (F2:A-
:B1) + IncI1 
(ST48)
blaTEM-1c, cmlA1, 
tet(A), sul3
iroN, mchF, ompT, sitC, hlyF, 
iroBCDE, iss, iucABCD, iutA, 
etsABC, finO, traT, cvaC
pEc-HUCA 4_3 62423 5 MOBP131
IncFII_RepA_superfamily 
(pfam02387) IncL/M blaOXA-48 nd
pEc-HUCA 4_4 33543 1* MOBP3
Rep3_superfamily 
(pfam01051) IncX4 nd nd
pEc-HUCA 4_5 6544 1 MOBP51 RNAI-II replication system ColE-like nd nd
pEc-HUCA 4_6 4502 1 MOBP51 RNAI-II replication system ColE-like nd nd
pEc-HUCA 4_7 1546 1* no-MOB RepA_HTH36_pfam13730 nd nd nd
Chr_Ec-HUCA 4 4996329 48 na na na gyrA-S83L
gad, mchF, iss, cnf1, pic, 
fimABCDEFGHI, ibeABC, 
iha, sfaX, usp, matB, betA, 
irp2, fyuA/psn, papBCDFHJK, 
hlyABCD
Ec-HUCA 5 pEc-HUCA 5_1 5251 1* MOBP51 RNAI-II replication system ColE-like nd nd
Chr_Ec-HUCA 5 5187005 184 na na na
blaOXA-48, 
blaCTX-M-15, gyrA-
S83L + D87N; 
parC-
S80I + E84V; 
parE-I529L, 
folA-W30R
gad, cnf1, pic, 
fimABCDEFGHI, ibeBC, 
iha, usp, matB, betA, 
irp2, sitC, fyuA/psn, sat, 
papBCDFGHJK, cnf1, 
hlyABCD, iss, iucABCD, iutA
Ec-HUCA 6
pEc-HUCA 6_1 45832 14 MOBF11
Rep3_superfamily 
(pfam01051) IncN (ST7) qnrS1, dfrA14
pEc-HUCA 6_2 5251 1* MOBP51 RNAI-II replication system ColE-like nd nd
Chr_Ec-HUCA 6 5218580 123 na na na
blaOXA-48, 
blaCTX-M-15, gyrA-
S83L + D87N; 
parC-
S80I + E84V; 
parE-I529L
gad, cnf1, pic, 
fimABCDEFGHI, ibeBC, 
iha, usp, matB, betA, 
irp2, sitC, fyuA/psn, sat, 
papBCDEFGHJK, cnf1, 
hlyABCD, iss, iucABCD, iutA
Continued
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inverted and deleted version of Tn1999.2 in Ec-HUCA 5 to 7 (Fig. 3). Tn1999.2 differs from Tn1999.1 by inser-
tion of IS1R into the IS1999 copy upstream of blaOXA-48, while in the deleted version, the IS1R-containing copy of 
IS1999 is truncated at the 5′ end9. IS1R enhances transcription of the downstream blaOXA-48 gene by providing an 
efficient promoter −35 box with an optimal 17-bp spacing with regard to the −10 box supplied by IS199912. This 
fact could explain the more frequent detection of Tn1999.2 and variants in comparison with Tn1999.16. Recently, 
the complete sequences of the first two ST131 blaOXA-48 plasmids have been reported25; in both, the gene was car-
ried by Tn1999.2, like in Ec-HUCA 4.
To identify the insertion sites of blaOXA-48 within the chromosomes of Ec-HUCA 5 to 7, assembled contigs 
were analysed. Three contigs containing sequences homologous to pOXA-48a (NC_01915411) and pRA35 
(LN8648219) were identified, and two of them were flanked by E. coli chromosomal genes. The three isolates 
shared an identical 21.9 Kb fragment in which the inverted and deleted version of Tn1999.2 was found, followed 
by genes previously detected in pOXA-48a and pRA35. This fragment, which is flanked by IS1R, constitutes an 
IS1R composite transposon, termed Tn62379. With the single exception of an isolate from Lebanon9, this is the 
first report of a Tn6237 insertion into the chromosome of ST131. The precise insertion site of the transposon was 
established by PCR mapping (Supplementary Figure S4). In Ec-HUCA 6 and 7, Tn6237 was placed between the 
tdcA (DNA-binding transcriptional activator) and tdcB (threonine dehydratase) genes, which are contiguous in 
other E. coli genomes. In the case of Ec-HUCA 5, Tn6237 was followed by tdcB but morA (putative dehydroge-
nase) was placed upstream. This organization may have resulted from inversion of the chromosomal segment 
spanning tdcA to morA. Consistent with its expected lack of specificity, IS1-flanked Tn6237, was also found in 
three other insertion sites within the E. coli chromosome, in isolates from the United Kingdom, Czech Republic 
and Lebanon9,30,31.
Resistance genes for other β-lactam and non-β-lactam antimicrobials. According to their phe-
notypes (Table 1), additional resistance genes were found in all OXA-48 isolates, contained in MOBF12/IncF, 
MOBF12/IncF + IncI1 and MOBF11/IncN plasmids or in the chromosome (Table 2). Thus, diverse plasmids act as 
vehicles for the spread of resistance genes between E. coli clones/subclones circulating in the same health area. 
Remarkably, blaCTX-M-15 appeared in different locations within the four ST131 isolates carrying it. Specifically, 
blaCTX-M-15 was chromosomally located in two out of the three isolates belonging to the H30-Rx subclone 
(Ec-HUCA 5 and 6), whereas in Ec-HUCA 7 it was carried by a MOBF11/IncN (ST7) plasmid of 48.7 Kb, together 
with qnrS1 and dfrA14, for plasmid-mediated quinolone resistance (PMQR) and trimethoprim resistance, respec-
tively. Interestingly, a slightly smaller MOBF11/IncN (ST7) plasmid of 45.8 Kb contained qnrS1 and dfrA14, but 
not blaCTX-M-15, in Ec-HUCA 6. The blaCTX-M-15 gene of the non-ST131 isolate (Ec-HUCA 2), was carried by a 
conjugative MOBF12/IncF plasmid of ca. 150 Kb15.
In the three ciprofloxacin resistant ST131 H30-Rx-OXA-48 isolates (Ec-HUCA 5 to 7; MIC > 32 mg/L), in 
silico analysis of the genomes revealed the distinct gyrA/parC allele combination (gyrA-S83L/D87N; parC-S80I/
E84V) previously reported for the H30 subclone32. The S83L mutation was also found in the gyrA gene of 
Ec-HUCA 1 and 4, which were resistant to nalidixic acid but susceptible to ciprofloxacin. Apart from qnrS1 found 
in Ec-HUCA 6 and 7, other PMQR genes, including additional qnr genes and qep or oqx genes, tested negative by 
bioinformatic methods. The genetic bases of most other resistances could be also established by in silico analysis 
(Tables 1 and 2), being of note the presence of a W30R mutation in the folA gene (dihydrofolate reductase) of 
Ec-HUCA 5, which was resistant to trimethoprim-sulfamethoxazole but lacked sul and dfr genes.
Virulence gene content and studies of virulence “in vivo”. Based on PCR-screening of 50 genes/
alleles characteristic of ExPEC, Ec-HUCA 2 and 4 showed the lowest and highest virulence scores, with 16 and 33 
virulence factors (VF), respectively. Of the five ST131 isolates, Ec-HUCA 4 was virotype D5 while Ec-HUCA 5 to 
7 were virotype E (Supplementary Figure S1; Supplementary Table S1). The virulence profile of the O16:H5-ST131 
isolate did not match any of the 12 virotypes included in the scheme33. Four out of the five ST131 (Ec-HUCA 4 to 
Isolate
Plasmids 
Chromosome Size (bp) Contigs
Relaxase 
proteina,e Replication roteina,e
Inc group 
(pMLST)b,e
Resistance 
genesc,e Virulence genesd,e
Ec-HUCA 7
pEc-HUCA 7_1 48671 14 MOBF11
Rep3_superfamily 
(pfam01051) IncN (ST7)
blaCTX-M-15, qnrS1, 
dfrA14 nd
pEc-HUCA 7_2 5251 1* MOBP51 RNAI-II replication system ColE-like nd nd
Chr_EcHUCA 7 5186594 125 na na na
blaOXA-48, gyrA-
S83L + D87N; 
parC-
S80I + E84V; 
parE-I529L
gad, cnf1, pic, 
fimABCDEFGHI, ibeBC, 
iha, usp, matB, betA, 
irp2, sitC, fyuA/psn, sat, 
papBCDEFGHJK, cnf1, 
hlyABCD, iss, iucABCD, iutA
Table 2. Plasmid content of OXA-48-producing Escherichia coli isolates and location of resistance and 
virulence genes. aRelaxase and replication proteins were identified by the use of homemade databases51. 
bIncompatibility groups were determined according to the PBRT scheme8 and pMLST subtypes according 
to the allele scheme in http://pubmlst.org/plasmid/. cAntimicrobial resistance genes were detected using the 
ARG-ANNOT48 and ResFinder49 databases. dVirulence genes were detected according to VirulenceFinder50 
and homemade databases. ena, not applicable; nd, not detected. fLength of the ICE (integrative and conjugative 
element)-containing contig. *Closed plasmids.
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7) and the ST83 (Ec-HUCA 3) isolates showed the ExPEC status, and all isolates except Ec-HUCA 1 were classi-
fied as UPEC.
PCR-screening results were complemented by in silico analysis of the genome sequences, which allowed 
the identification of additional VFs, mainly encoded by genes located in the chromosome but also on plasmids 
(Table 2). Like before, the highest VF score was obtained for Ec-HUCA 4, followed by the ST131 H30-Rx-OXA-48 
isolates (Ec-HUCA 5 to 7), which shared the same profile consisting of four operons and 15 individual genes. In 
contrast, a score of 16 was obtained for Ec-HUCA 1, the ST131 isolate with undefined virotype.
With regard to non-ST131 isolates, 27 VFs were detected in Ec-HUCA 2 and only 13 in Ec-HUCA 3. 
Interestingly, the plasmid virulence genes of Ec-HUCA 2 and 4 were nearly identical, and some virulence genes 
have chromosomal and plasmid copies (iss in Ec-HUCA 2, and mchF and iss in Ec-HUCA 4), providing regions 
of homology for interaction between the two replicons.
Figure 1. Phylogenetic tree of IncL plasmids from OXA-48-producing isolates of Escherichia coli. The tree is 
based on SNPs found in the core genome (19,995 bp +/− 45 bp; 26 CDS with ≥80% identity, ≥60% pairwise 
alignment coverage), common to 31 IncL (18), IncM1 (seven) and IncM2 (six) plasmids. Bootstrap support 
values of 1,000 replicates are shown at the nodes. Clusters corresponding to each group/subgroup are enclosed 
in yellow, pink and blue boxes. IncL plasmids are more closely related to IncM2 than to IncM1 plasmids.
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Finally, the intrinsic extraintestinal virulence of the OXA-48-producing E. coli was assessed in a mouse sepsis 
model. Within a seven day experiment, all mice challenged with E. coli CFT703 (positive control) died, compared 
with none of the mice challenged with E. coli MG1655 (negative control), which remained healthy. All OXA-48 
isolates showed lethality as low as ≤10% and only three (Ec-HUCA 2, 6 and 7) caused the death of one out of the 
ten inoculated mice. In contrast, all isolates caused local inflammatory response, with extensive subcutaneous 
necrosis, in the surviving mice (Supplementary Table S2). Previously, we observed different virulence patterns in 
the final lethality, the rapidity in causing death and the inflammation-causing ability of ST131 isolates in corre-
lation with the virotype, with the highest lethality (≥80% of mice challenged killed) shown by virotypes A, B, C 
and D1. By contrast, isolates within virotypes D2, D3 and D4 led to different outcomes, and isolates of virotype 
E showed the lowest final lethality, varying from 10 to 40% of the challenged mice. We also observed that certain 
ST131 isolates of virotypes C, D, and E induced an acute inflammatory response in the inoculation region22, like 
those in this study. There are few comparable in vivo studies and this is the first one assaying OXA-48-producing 
isolates. Results derived from the sepsis model might be consistent with the clinical nature of the isolates, not 
involved in severe disease but recovered from surgical wounds and UTIs. Future studies would be necessary to 
investigate the mechanisms responsible for the differences in lethality within ST131 virotypes.
Phylogenomics of the OXA-48-producing isolates. The phylogenetic context of the OXA-48-producing 
E. coli was assessed by comparison with 28 E. coli genomes with different STs, PSTs, virotypes and fimH alleles (Fig. 4, 
Supplementary Table S3). All ST131 isolates grouped in a single cluster which was further divided into subclusters 
according to clade, virotype and serotype. In agreement with their assignment to phylogroup B2, the ST131 cluster 
was genetically closer to ST83 (also B2) than to ST58 (phylogroup B1). It is of note that only two SNPs differences 
Figure 2. BRIG (Blast Ring Image generator) comparison of the IncL plasmids from OXA-48-producing 
Escherichia coli isolates and representative IncL, IncM1 and IncM2 plasmids. Each ring corresponds to a 
plasmid (indicated at the right of the figure together with the color code). Plasmid pOXA-48 (inner black ring) 
was used as a reference. Their genes are shown in the outer ring, represented by black arrows that also indicate 
the direction of transcription.
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were found between the COG-based core genomes of Ec-HUCA 6 and 7, and that both differed from Ec-HUCA 5 
by 14 SNPs. Comparing these three highly similar isolates using SNP analysis and conventional PFGE, we found that 
both approaches discriminated between Ec-HUCA 5 vs 6 and 7, the latter displaying 100% identity between them 
and 88.4% with Ec-HUCA 5 by PFGE (Supplementary Figure S1). As shown in Table 1, these clonal isolates were 
detected in a primary-care centre, in the emergency unit of the HUCA and in the geriatric unit of a long-term facil-
ity. Thus, the H30-Rx-OXA-48 subclone, with the chromosomally located carbapenemase gene, is circulating both 
in the community and health-care institutions, which indicates transmission between the two settings. The number 
of SNPs between these and other isolates progressively increased according to the ST/PST and phylogroup affiliation, 
with averages of 3,755, 8334, 19,787 and 79,640, with regard to Ec-HUCA 4, 1, 3 and 2, respectively.
Concerning Ec-HUCA 5, 6 and 7, they are classified as virotype E and belong to clade C (PST43/H30), which 
comprises previously reported ST131 genomes with virotypes A, B and C23. None of these ST131 references car-
ried the blaOXA-48 gene, although BIDMC20B, BWH24 and MNCRE-44 (virotype C) harbour the blaKPC-3 carbap-
enemase gene, always located on large conjugative plasmids23,34,35. It is important to note that this is the first study 
where ST131 virotype E genomes have been sequenced. In the clades A (PST506/H41) and B (PST9/H22-234), 
containing the Ec-HUCA 1 and 4 genomes, respectively, only Ecol_743 harbours the blaOXA-48 gene (located on 
a 69 Kb plasmid named pEC743_OXA48), while Ecol_448 contains the closely related class D beta-lactamase 
blaOXA-163 gene (pEC448_OXA163, 71 Kb plasmid)25.
According to our results, diverse OXA-48-producing E. coli clones are circulating in Oviedo, a situation jus-
tified in part by the conjugative potential of the IncL plasmid carrying the blaOXA-48 gene. Additional plasmids 
also play a role as vehicles of resistance and/or virulence genes. Treatment of the affected patients represents a 
serious challenge since all except one isolate were MDR. So, antimicrobial stewardship policies, new antimicrobial 
therapy approaches and control measures are necessary to combat the infections caused by these bacteria, and to 
control further dispersal.
Material and Methods
Epidemiological background of the OXA-48-producing isolates. The isolates were recovered from 
wound infections or UTIs between 2012 and 2015 (Table 1). Like Ec-HUCA 1 to 315, Ec-HUCA 4 caused a hospi-
tal-acquired infection and affected a critical patient exposed to long-term hospitalization and prolonged antimi-
crobial treatment in the HUCA. The remaining isolates were recovered from patients attended at a primary care 
centre (Ec-HUCA 5), the emergency unit of the HUCA (Ec-HUCA 6), and the geriatric unit of a long-term care 
facility associated with the hospital (Ec-HUCA 7).
Antimicrobial susceptibility testing and plasmid analysis. For the new isolates, antimicrobial suscep-
tibility was determined by disk (Oxoid, Madrid, Spain or Becton Dickinson, Sparks, MD, USA) diffusion assays 
and the Microscan system (MicroScan, Beckman Coulter, CA, USA), which also allows bacterial identification. 
Figure 3. Genetic environment of the blaOXA-48 gene. (A) Structures of the Tn1999-like transposons and 
adjacent DNA from the IncL blaOXA-48 plasmids of Ec-HUCA 1, 2, 3 and 4. (B) Structure of the inverted and 
deleted Tn1999.2 transposon and the adjacent DNA including the insertion sites in the chromosomes of Ec-
HUCA 5, 6 and 7. Open reading frames are represented by arrows indicating the direction of transcription and 
having different fillings: orange, IS1999; black dots, IS1; red, blaOXA-48; purple, lysR; blue, IncL plasmid genes; 
green, E. coli chromosomal genes. The Tn1999-like structures are highlighted by yellow boxes.
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MICs for erythromycin were determined by broth microdilution following CLSI guidelines36. MICs for carbap-
enems (ertapenem, imipenem and meropenem) were obtained with Etest strips (bioMérieux, Marcy-l’Étoile, 
France). Results were interpreted according to CLSI breakpoints36. Carbapenemase production was confirmed 
by the modified Hodge and Carba NP tests37. Identification of genes encoding resistance to carbapenems and 
broad-spectrum cephalosporins, and plasmid analysis were performed as reported8,15,38. The genetic context of 
the blaOXA-48 gene was determined by PCR mapping (see Supplementary Table S4 and Supplementary Figure S4).
Typing, subtyping and phylogenetic grouping of the isolates. E. coli isolates were characterized 
with regard to O:H serotype and fimH alleles (for type 1 fimbrial adhesion)39–41. The STs were established fol-
lowing the MLST schemes of Achtman (http://mlst.warwick.ac.uk/mlst/dbs/Ecoli) and the Pasteur Institute 
(http://bigsdb.pasteur.fr/ecoli/ecoli.html). The XbaI-PFGE profiles were determined according to PulseNet pro-
tocol (http://www.pulsenetinternational.org/), imported into BioNumerics (Applied Maths, St-Martens-Latern 
Belgium) and clustered by Dice/UPGMA. Fifty genes/alleles encoding virulence factors (VF) were screened by 
PCR (Supplementary Table S5). Isolates were presumptively designated as ExPEC if positive for two or more 
of five markers and as uropathogenic (UPEC) if positive for three or more of four markers (Supplementary 
Figure 4. Phylogenetic tree of the OXA-48-producing Escherichia coli genomes. The tree is based on the core 
genome SNPs (3,154,218 bp ± 1716 bp; 3185 CDS with ≥80% identity, ≥60% pairwise alignment coverage). 
Bootstrap support values of 1,000 replicates are shown at the nodes. The ST131 clades are indicated with blue 
(Clade A, PST506/fimH41), green (Clade B, PST9/fimH22-234) and red (Clade C, PST43/fimH30) circles.
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Table S1)42,43. The virotype of the ST131 isolates was established according to the scheme described by Dahbi 
et al.33. Assignment to the main phylogroups (A, B1, B2 and D) was based on the protocol of Clermont et al.17.
Genome sequencing, assembly and analysis. Total DNA from E. coli isolates was extracted with the 
QIAmp DNA Mini Kit (Qiagen). Libraries were prepared using the TruSeq PCR-free DNA Sample Preparation 
Kit (Illumina) at the sequencing facility of the University of Cantabria. Paired-end 100 bp reads (550 bp insert 
size) were sequenced in a HiSeq. 2500 (Health in Code Facility). Reads were assembled with the VelvetOptimiser.
pl script of Velvet software44. Serotype, MLST, fimH alleles and virulence gene profiles were in silico determined 
with SerotypeFinder v1.145,46, and homemade MLST (Achtman and Pasteur schemes), fimH and virotype data-
bases47. Antimicrobial resistance genes were detected using the ARG-ANNOT48 and ResFinder49 databases; vir-
ulence gene content was established with VirulenceFinder and homemade databases50.
For phylogenetic analysis, core genome was defined as described by Lanza et al.23, using the genomes of the E. 
coli isolates from the HUCA plus reference full-genomes retrieved from GenBank-NCBI (ftp://ftp.ncbi.nlm.nih.
gov/genomes/genbank/bacteria/) and Enterobase (http://enterobase.warwick.ac.uk/species/index/ecoli).
Plasmid reconstruction from WGS data and analysis. Plasmid reconstructions were based on the 
PLACNET method23. Contig analysis was performed against complete bacterial genomes and plasmids from 
GenBank-NCBI. Relaxase proteins (REL) and Replication Initiation Proteins (RIP) were identified using in-house 
databases23,51. Incompatibility groups and pMLST subtypes were experimentally8,52 and/or in silico determined 
(http://pubmlst.org/plasmid/). Reconstructed blaOXA-48 IncL plasmids and references belonging to the IncL and 
IncM groups were compared using BRIG53, and a phylogenetic tree was built from variable positions (SNPs) in 
genes encoding core proteins.
Mouse lethality assay. A mouse sepsis model was used to assess extraintestinal virulence of the isolates22. 
For each one, 10 outbred female RjOrl:Swiss mice (3–4 weeks old; Janvier Labs, France) received a subcutaneous 
injection into the nape of the neck of approximately 2 × 108 CFU of log-phase bacteria. After inoculation, mice 
were clinically inspected along one week. Time of death and local presence of lesions (acute inflammation in the 
region of inoculation) were recorded for each mouse. Surviving mice were euthanatized on day seven by cervical 
dislocation. In each assay, two control isolates were included: E. coli K-12 MG1655 which does not kill mice by 
seven days post-challenge, and E. coli CFT073 which shows a lethality of ≥80% by seven days post-challenge. 
Results of lethality were indicated as the number of mice killed within 24 h and within seven days post-injection.
Ethics statement. All experimental protocols dealing with bacteria from human samples were approved by 
the ethics committee of the HUCA.
All animal experimentation was conducted following European (Directive 2010/63/EU on the protection of 
animals used for scientific purposes) and National (RD 53/2013) regulations for transport, housing and care of 
laboratory animals. The protocol used was approved by the Animal Welfare Committee of the Veterinary Faculty 
in Lugo, University of Santiago de Compostela (AE-LU-002/14-1).
Data availability. This Whole Genome Shotgun project has been deposited at DDBJ/ENA/GenBank 
under accession numbers NBSZ00000000, NBSY00000000, NBSX00000000, NBSW00000000, NBSV00000000, 
NBSU00000000, NBST00000000 for Ec-HUCA 1 to 7, respectively. All the samples are part of BioProject 
PRJNA381431 and correspond to BioSample IDs SAMN06676454 to SAMN06676460.
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